Fund Holdings — VR Adviser, LLC

Total Portfolio Value:
$2.10B
Total Bought:
$626.89M
Total Sold:
$437.48M
Net Transaction:
+$189.41M
Notable People:
Evan Wolfe Neu, Jessica Tong Baron
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Apogee Therapeutics Inc8,493,3218,493,3210$237.30M$564.38M26.85%+$327.08M
4d Molecular Therapeutics In3,424,0314,400,000+975,969$69.37M$140.18M6.67%+$70.81M
Ocular Therapeutix, Inc.(OCUL)7,775,76012,762,462+4,986,702$34.68M$116.14M5.52%+$81.46M
Spyre Therapeutics, Inc.(SYRE)2,372,7142,171,782-200,932$51.06M$82.38M3.92%+$31.31M
Merus N V2,148,2141,790,214-358,000$59.08M$80.61M3.83%+$21.54M
Pharvaris N V
COM
3,395,6063,395,6060$95.25M$78.47M3.73%-$16.77M
Kalvista Pharmaceuticals Inc4,092,7316,249,731+2,157,000$50.14M$74.12M3.53%+$23.99M
Enliven Therapeutics Inc2,954,9024,026,331+1,071,429$40.90M$70.82M3.37%+$29.93M
Viridian Therapeutics, Inc.(VRDN)3,882,6233,882,671+48$84.56M$67.99M3.23%-$16.58M
Dianthus Therapeutics, Inc.(DNTH)927,7062,094,373+1,166,667$9.65M$62.83M2.99%+$53.18M
Dyne Therapeutics, Inc.(DYN)2,173,9132,173,9130$28.91M$61.72M2.94%+$32.80M
Applied Therapeutics Inc6,250,0009,075,000+2,825,000$20.94M$61.71M2.94%+$40.77M
ORIC Pharmaceuticals, Inc.(ORIC)2,428,3854,394,527+1,966,142$22.34M$60.42M2.87%+$38.08M
Astria Therapeutics Inc3,225,8063,608,645+382,839$24.77M$50.79M2.42%+$26.02M
Mersana Therapeutics Inc11,328,00011,328,0000$26.28M$50.75M2.41%+$24.47M
Engene Holdings Inc
COM
02,565,841+2,565,841$0$43.49M2.07%+$43.49M
Praxis Precision Medicines, Inc.(PRAX)353,626706,126+352,500$7.88M$43.09M2.05%+$35.21M
Hillevax Inc2,075,0002,075,0000$33.30M$34.51M1.64%+$1.20M
Cogent Biosciences, Inc.(COGT)4,684,1675,129,167+445,000$27.54M$34.47M1.64%+$6.93M
Edgewise Therapeutics, Inc.(EWTX)01,818,182+1,818,182$0$33.16M1.58%+$33.16M
Cabaletta Bio, Inc.(CABA)2,563,9521,563,952-1,000,000$58.20M$26.68M1.27%-$31.52M
Arvinas, Inc.(ARVN)627,788627,7880$25.84M$25.92M1.23%+$75.3K
Taysha Gene Therapies, Inc.(TSHA)10,412,8729,000,000-1,412,872$18.43M$25.83M1.23%+$7.40M
Aquestive Therapeutics Inc05,555,555+5,555,555$0$23.67M1.13%+$23.67M
Terns Pharmaceuticals Inc4,497,1173,410,058-1,087,059$29.19M$22.37M1.06%-$6.82M
Adverum Biotechnologies Inc01,556,419+1,556,419$0$22.01M1.05%+$22.01M
Celcuity Inc.(CELC)1,885,538970,000-915,538$27.47M$20.95M1.00%-$6.52M
ABIVAX Société AnonymeADS(ABVX)998,5701,345,780+347,210$10.68M$19.24M0.92%+$8.56M
Immatics N.V.SHS(IMTX)01,750,000+1,750,000$0$18.39M0.87%+$18.39M
Lyra Therapeutics Inc2,575,5932,576,093+500$13.50M$16.02M0.76%+$2.53M
CG Oncology, Inc.(CGON)0350,000+350,000$0$15.37M0.73%+$15.37M
Century Therapeutics, Inc.(IPSC)03,405,133+3,405,133$0$14.23M0.68%+$14.23M
Trevi Therapeutics, Inc.(TRVI)3,422,3973,422,675+278$4.59M$11.81M0.56%+$7.22M
Tenaya Therapeutics, Inc.(TNYA)01,555,556+1,555,556$0$8.14M0.39%+$8.14M
Mineralys Therapeutics, Inc.(MLYS)0555,554+555,554$0$7.17M0.34%+$7.17M
Acelyrin Inc937,113937,1130$6.99M$6.33M0.30%-$665.4K
EyePoint, Inc.(EYPT)250,000250,0000$5.78M$5.17M0.25%-$610.0K
Olema Pharmaceuticals, Inc.(OLMA)77,04277,0420$1.08M$872.1K0.04%-$208.8K
Adverum Biotechnologies Inc5,147,5470-5,147,547$3.88M$0—-$3.88M
Ambrx Biopharma Inc2,070,0000-2,070,000$29.48M$0—-$29.48M
GH Research PLC(GHRS)1,318,3270-1,318,327$7.65M$0—-$7.65M
Milestone Pharmaceuticals Inc.(MIST)925,0480-925,048$1.54M$0—-$1.54M
Rayzebio Inc4,030,4710-4,030,471$250.57M$0—-$250.57M
Rhythm Pharmaceuticals, Inc.(RYTM)495,9830-495,983$22.80M$0—-$22.80M
Savara Inc.(SVRA)3,500,0000-3,500,000$16.45M$0—-$16.45M
Page 1 of 1
VR Adviser, LLC — 13F Holdings — Q1 2024 | TickerTrail